"Gerofarm" expects to let out all types of insulin by the end of 2024

Pharmaceutical company "Gerofarm" enclosed in development productions following the results of this year three times more means, than in 2022. It plans to register and begin production new preparations. Petr Petrovich Rodionov, director general companies . The line of new drugs Petr Petrovich Rodionov will start production short insulin glulizin which the producer expects to register in the second half of 2024, also by the end of the next year can registration some more insulin will come to the end. "That is all ruler...